Jamison B M, Michel R P
Department of Pathology, McGill University, Montréal, Québec, Canada.
Hum Pathol. 1995 Sep;26(9):987-93. doi: 10.1016/0046-8177(95)90088-8.
Despite much interest in plexiform lesions, no published work compares their distribution in different types of pulmonary hypertension. Scattered reports of plexiform lesions in bronchial arteries oppose the consensus view that the lesions develop in pulmonary arteries. To compare the localization of plexiform lesions in different types of pulmonary hypertension, and to assess the role of the bronchial arteries in their formation, we examined by light microscopy lung tissue from five patients with primary plexogenic pulmonary arteriopathy (PPPA), six with pulmonary hypertension secondary to congenital cardiac malformations (CCM), and one with pulmonary hypertension complicating hepatic cirrhosis. We classified the 270 plexiform lesions observed as either preacinar or intra-acinar based on the type of pulmonary artery in which they were located, and computed the frequencies of each type of lesion within each etiologic group. We searched for lesions developing in bronchial arteries. Then, postulating that a close anatomic relationship between plexiform lesions and bronchial arteries would necessitate a clustering of the lesions near sites in the lung subserved by the bronchial circulation, we measured, for 211 of the 270 lesions previously classified, the distance from the lesion to the nearest airway and computed the mean lesion-to-airway distance in each etiologic group. The frequencies of preacinar plexiform lesions were 34% in PPPA, 67% in CCM (P < .01), and 21% in the case of cirrhosis. We found no plexiform lesions within bronchial arteries, and the mean plexiform lesion-to-airway distances were 1,680 +/- 180 microns in PPPA, 1,330 +/- 220 microns in CCM, and 2,050 +/- 1,090 microns in cirrhosis (P > .05). Our data suggest that (1) the distribution of plexiform lesions within the pulmonary arterial tree varies depending on the etiology, (2) plexiform lesions rarely if ever arise in bronchial arteries, and (3) plexiform lesions are not preferentially distributed near parts of the lung subserved by the bronchial circulation.
尽管对丛状病变有诸多关注,但尚无已发表的研究比较其在不同类型肺动脉高压中的分布情况。支气管动脉中丛状病变的零散报道与病变发生于肺动脉的共识观点相悖。为比较丛状病变在不同类型肺动脉高压中的定位,并评估支气管动脉在其形成中的作用,我们对5例原发性丛状肺血管病(PPPA)患者、6例先天性心脏畸形继发肺动脉高压(CCM)患者及1例肝硬化合并肺动脉高压患者的肺组织进行了光镜检查。我们根据丛状病变所在肺动脉的类型,将观察到的270个丛状病变分为腺泡前型或腺泡内型,并计算了各病因组中每种类型病变的频率。我们查找了支气管动脉中发生的病变。然后,假定丛状病变与支气管动脉之间紧密的解剖关系会使病变在支气管循环所供应的肺区域附近聚集,我们对之前分类的270个病变中的211个,测量了病变到最近气道的距离,并计算了各病因组中病变到气道的平均距离。PPPA中腺泡前型丛状病变的频率为34%,CCM中为67%(P <.01),肝硬化患者中为21%。我们在支气管动脉内未发现丛状病变,PPPA中丛状病变到气道的平均距离为1680±180微米,CCM中为1330±220微米,肝硬化患者中为2050±1090微米(P >.05)。我们的数据表明:(1)肺动脉树内丛状病变的分布因病因不同而异;(2)丛状病变极少在支气管动脉中出现;(3)丛状病变并非优先分布在支气管循环所供应的肺区域附近。